The top documents tagged [statin trials]

Attualità nellimpiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna
Documents Attualità nellimpiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna

214 views

Psoriasis
Documents Psoriasis

1.352 views

Improve it slides
Health & Medicine Improve it slides

1.498 views

By Apurva D. Shah, FACC Northside Heart and Vascular Institute
Documents By Apurva D. Shah, FACC Northside Heart and Vascular Institute

226 views

IMProved Reduction of Outcomes: Vytorin Efficacy International Trial A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and
Documents IMProved Reduction of Outcomes: Vytorin Efficacy International Trial A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and

221 views

Residual risk: Is LDL target enough?. An interpretation of the continuous relationship between LDL-C and CVD Therefore, many men and most women with heart
Documents Residual risk: Is LDL target enough?. An interpretation of the continuous relationship between LDL-C and CVD Therefore, many men and most women with heart

220 views

Common Questions in Lipids 2010 Mehul Bhatt, MD Athens Heart Center
Documents Common Questions in Lipids 2010 Mehul Bhatt, MD Athens Heart Center

217 views

Efficacy of statins in primary and secondary prevention of CV events - well established Meta-analyses of RCTs : - demonstrated dramatic reductions in
Documents Efficacy of statins in primary and secondary prevention of CV events - well established Meta-analyses of RCTs : - demonstrated dramatic reductions in

215 views

LIPID LOWERING IN T2D (The Lower the Better?) CONS… TARGETING HARD CVD END POINTS Charles SAAB MD Consultant Endocrinologist DCRP Sacre-Coeur University
Documents LIPID LOWERING IN T2D (The Lower the Better?) CONS… TARGETING HARD CVD END POINTS Charles SAAB MD Consultant Endocrinologist DCRP Sacre-Coeur University

215 views

Cardiovascular New Drug Update C. Wayne Weart, Pharm D, FASHP, FAPhA, BCPS Professor of Clinical Pharmacy and Outcome Sciences South Carolina College of
Documents Cardiovascular New Drug Update C. Wayne Weart, Pharm D, FASHP, FAPhA, BCPS Professor of Clinical Pharmacy and Outcome Sciences South Carolina College of

215 views

Role of Fenofibrate in Diabetic Dyslipidemia. Diabetic Dyslipidaemia Occurs in type 2 diabetes mellitus High levels of triglycerides Low levels of HDL-C
Documents Role of Fenofibrate in Diabetic Dyslipidemia. Diabetic Dyslipidaemia Occurs in type 2 diabetes mellitus High levels of triglycerides Low levels of HDL-C

219 views